Journal
BIOTECHNOLOGY AND BIOENGINEERING
Volume 113, Issue 5, Pages 930-943Publisher
WILEY
DOI: 10.1002/bit.25851
Keywords
antimicrobials; Cas9; genetic control; genetic circuits; genome engineering; undomesticated microbes
Categories
Funding
- National Science Foundation [CBET-1403135, MCB-1452902]
- National Institutes of Health [5T32GM008776-15]
- Direct For Biological Sciences
- Div Of Molecular and Cellular Bioscience [1452902] Funding Source: National Science Foundation
- Div Of Chem, Bioeng, Env, & Transp Sys
- Directorate For Engineering [1403135] Funding Source: National Science Foundation
Ask authors/readers for more resources
CRISPR-Cas systems have rapidly transitioned from intriguing prokaryotic defense systems to powerful and versatile biomolecular tools. This article reviews how these systems have been translated into technologies to manipulate bacterial genetics, physiology, and communities. Recent applications in bacteria have centered on multiplexed genome editing, programmable gene regulation, and sequence-specific antimicrobials, while future applications can build on advances in eukaryotes, the rich natural diversity of CRISPR-Cas systems, and the untapped potential of CRISPR-based DNA acquisition. Overall, these systems have formed the basis of an ever-expanding genetic toolbox and hold tremendous potential for our future understanding and engineering of the bacterial world. Biotechnol. Bioeng. 2016;113: 930-943. (c) 2015 Wiley Periodicals, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available